Finally, the identified IL1R1+ CAF subtype is correlated with lowered survival in CRC patients belonging to Consensus Molecular Subtype 4 (CMS4)—a molecular subtype of CRC that shows the lowest therapy response and overall survival. The gene discussed is IL1R1; the disease is colorectal carcinoma.